Price $17.02 |
Market Cap
114.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
12.9
|
P/B
0.83
|
P/S
1.33
|
Dividend %
-
|
|
P/CF
12.4
|
P/FCF
7.7
|
Op. Cash Flow
19.6K
|
FCF
2.2
|
|
Op. Margin
16.10%
|
Net Margin
11.00%
|
ROE
7.20%
|
ROI
8.70%
|
|
ROA
5.20%
|
EPS Growth
-15.50%
|
Current Ratio
5.1
|
Debt/Equity
1.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $29.54 | - | - | 10.52B | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.13 | - | - | 60.7M | Strong Buy |
| Lannett Company, Inc. (LCI) | $4.72 | - | - | 186.5M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.25 | - | - | 53.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
